Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

CardioComm Solutions, Inc. (V:EKG)

Business Focus: Medical Software & Technology Services

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
Company Contact
Address: 18 Wynford Drive, Suite 305
NORTH YORK ON M3C 3S2
Tel: N/A
Website: https://www.cardiocommsolutions.com
IR: See website
Key People
Etienne Grima
Chief Executive Officer, Corporate Secretary, Director
Josee Bertrand
Chief Financial Officer
 
Business Overview
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Company's device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.
Financial Overview
For the fiscal year ended 31 December 2023, CardioComm Solutions Inc revenues decreased 12% to C$876K. Net loss increased from C$2K to C$97K. Revenues reflect Hardware sales decrease of 61% to C$187K, Services decrease of 5% to C$182K. Higher net loss reflects Development of advanced software and sale of ECG segment loss increase from C$77K to C$243K.
Employees: 16 as of Dec 31, 2002
Reporting Currency: Canadian Dollars
Enterprise value: $1.90M as of Dec 31, 2023
Annual revenue (TTM): $0.88M as of Dec 31, 2023
EBITDA (TTM): -$0.18M as of Dec 31, 2023
Net annual income (TTM): -$0.10M as of Dec 31, 2023
Free cash flow (TTM): -$0.06M as of Dec 31, 2023
Net Debt Last Fiscal Year: $0.40M as of Dec 31, 2023
Shares outstanding: 151,164,638 as of Dec 31, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization